Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kofeez is a broad-spectrum homeopathic cough syrup developed and manufactured by Medisynth Chemicals. It is indicated for the symptomatic relief of various respiratory conditions, including dry cough, productive cough, smoker's cough, bronchitis, asthma, and whooping cough. The formulation is a combination of four homeopathic mother tinctures: *Blatta orientalis* (targeted at asthmatic cough and congestion), *Bryonia alba* (for dry, painful cough), *Ipecacuanha* (for persistent cough with difficult expectoration), and *Zingiber* (for soothing the throat and hoarseness). Marketed as a non-drowsy formulation suitable for both adults and children, it is designed to provide immediate soothing relief followed by sustained action.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kofeez.